NDC 51672-4130

Lamotrigine 25 mg tablet

On the label: Caraco Pharmaceutical Laboratories, Ltd..

Where it's made

Recalls

• Dec 20, 2019 · Class I · Taro Pharmaceuticals U.S.A., Inc.
  Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
  Lots: Lot #: 331771, Exp. June 2021

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Lamotrigine: every company that makes it

Form

tablet, oral

Strength

25 mg

Approval

ANDA ANDA078525

On the market since

Jan 27, 2009

Package NDCs

51672-4130-0 51672-4130-1 51672-4130-3 51672-4130-4 51672-4130-6

Official label

DailyMed (National Library of Medicine), updated Jun 3, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?